Compounds > ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination
Page last updated: 2024-09-04

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and pentylenetetrazole

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with pentylenetetrazole in 1 studies

Compound Research Comparison

Studies
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Trials
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Recent Studies (post-2010)
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Studies
(pentylenetetrazole)		Trials
(pentylenetetrazole)		Recent Studies (post-2010) (pentylenetetrazole)
24506,737301,496

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frye, CA; Harney, JP; Rhodes, ME; Talluri, J1

Other Studies

1 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and pentylenetetrazole

ArticleYear
Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.
    Epilepsy & behavior : E&B, 2005, Volume: 7, Issue:2

    Topics: Allylamine; Analysis of Variance; Animals; Animals, Newborn; Diet; Disease Models, Animal; Drug Combinations; Estrous Cycle; Female; Meperidine; Pentylenetetrazole; Radioimmunoassay; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Steroids; Vagina

2005